AusPAR: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage

Australian Public Assessment Report

AusPAR

AusPAR: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [PDF, 633.59 KB]

AusPAR: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [Word, 525.58 KB]

Attachment: Product Information: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [PDF, 339.79 KB]

Attachment: Product Information: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [Word, 103.26 KB]

Attachment: Extract from the Clinical Evaluation Report: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [PDF, 902.78 KB]

Attachment: Extract from the Clinical Evaluation Report: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage [Word, 1.8 MB]

Device/Product Name

FluQuadri, FluQuadri Junior

Active ingredients

Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage

AusPAR Date

6 February 2015

Published

20 March 2015

Submission Number

PM-2013-02401-1-2

Submission Type

New biological entity

Decision

Approved

This webpage on the TGA website was printed on 12 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/auspar/auspar-influenza-virus-haemagglutinin-h1n1-h3n2-b-victoria-lineage-b-yamagata-lineage

Sub menu

AusPAR: Influenza Virus Haemagglutinin H1N1, H3N2, B Victoria lineage, B Yamagata lineage

Help us improve the Therapeutic Goods Administration site